Literature DB >> 18805423

Marked differences between atrial and ventricular gene-expression remodeling in dogs with experimental heart failure.

Sophie Cardin1, Patricia Pelletier, Eric Libby, Sabrina Le Bouter, Ling Xiao, Stefan Kääb, Sophie Demolombe, Leon Glass, Stanley Nattel.   

Abstract

Congestive heart failure (CHF) causes arrhythmogenic, structural and contractile remodeling, with important atrial-ventricular differences: atria show faster and greater inflammation, cell-death and fibrosis. The present study assessed time-dependent left atrial (LA) and ventricular (LV) gene-expression changes in CHF. Groups of dogs were submitted to ventricular tachypacing (VTP, 240 bpm) for 24 h or 2 weeks, and compared to sham-instrumented animals. RNA from isolated LA and LV cardiomyocytes of each dog was analyzed by canine-specific microarrays (>21,700 probe-sets). LA showed dramatic gene-expression changes, with 4785 transcripts significantly-altered (Q<5) at 24-hour and 6284 at 2-week VTP. LV gene-changes were more limited, with 52 significantly-altered at 24-hour and 130 at 2-week VTP. Particularly marked differences were seen in ECM genes, with 153 changed in LA (e.g. approximately 65-fold increase in collagen-1) at 2-week VTP versus 2 in LV; DNA/RNA genes (LA=358, LV=7); protein biosynthesis (LA=327, LV=14); membrane transport (LA=230, LV=8); cell structure and mobility (LA=159, LV=6) and coagulation/inflammation (LA=147, LV=1). Noteworthy changes in LV were genes involved in metabolism (35 genes; creatine-kinase B increased 8-fold at 2-week VTP) and Ca(2+)-signalling. LA versus LV differential gene-expression decreased over time: 1567 genes were differentially expressed (Q<1) at baseline, 1499 at 24-hour and 897 at 2-week VTP. Pathway analysis revealed particularly-important changes in LA for mitogen-activated protein-kinase, apoptotic, and ubiquitin/proteasome systems, and LV for Krebs cycle and electron-transfer complex I/II genes. VTP-induced CHF causes dramatically more gene-expression changes in LA than LV, dynamically altering the LA-LV differential gene-expression pattern. These results are relevant to understanding chamber-specific remodeling in CHF.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18805423     DOI: 10.1016/j.yjmcc.2008.08.007

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  15 in total

Review 1.  Proteasome inhibitors and cardiac cell growth.

Authors:  Nadia Hedhli; Christophe Depre
Journal:  Cardiovasc Res       Date:  2009-07-03       Impact factor: 10.787

Review 2.  Role of various proteases in cardiac remodeling and progression of heart failure.

Authors:  Alison L Müller; Naranjan S Dhalla
Journal:  Heart Fail Rev       Date:  2012-05       Impact factor: 4.214

3.  Looking into the left atrial crystal ball: a ray of hope for patients with organic mitral regurgitation.

Authors:  Robert A Levine; Stanley Nattel
Journal:  J Am Coll Cardiol       Date:  2010-08-10       Impact factor: 24.094

Review 4.  The ubiquitin-proteasome system in cardiac proteinopathy: a quality control perspective.

Authors:  Huabo Su; Xuejun Wang
Journal:  Cardiovasc Res       Date:  2009-08-20       Impact factor: 10.787

5.  Transcriptomic and proteomic analysis of global ischemia and cardioprotection in the rabbit heart.

Authors:  James D McCully; Monoj K Bhasin; Christian Daly; Manuel C Guerrero; Simon Dillon; Towia A Liberman; Douglas B Cowan; John D Mably; Francis X McGowan; Sidney Levitsky
Journal:  Physiol Genomics       Date:  2009-05-19       Impact factor: 3.107

6.  Chamber-specific differences in human cardiac fibroblast proliferation and responsiveness toward simvastatin.

Authors:  Farhan Rizvi; Alessandra DeFranco; Ramail Siddiqui; Ulugbek Negmadjanov; Larisa Emelyanova; Alisher Holmuhamedov; Gracious Ross; Yang Shi; Ekhson Holmuhamedov; David Kress; A Jamil Tajik; Arshad Jahangir
Journal:  Am J Physiol Cell Physiol       Date:  2016-06-22       Impact factor: 4.249

7.  Differential effects of the peroxynitrite donor, SIN-1, on atrial and ventricular myocyte electrophysiology.

Authors:  Ingrid M Bonilla; Arun Sridhar; Yoshinori Nishijima; Sandor Györke; Arturo J Cardounel; Cynthia A Carnes
Journal:  J Cardiovasc Pharmacol       Date:  2013-05       Impact factor: 3.105

Review 8.  Animal models of arrhythmia: classic electrophysiology to genetically modified large animals.

Authors:  Sebastian Clauss; Christina Bleyer; Dominik Schüttler; Philipp Tomsits; Simone Renner; Nikolai Klymiuk; Reza Wakili; Steffen Massberg; Eckhard Wolf; Stefan Kääb
Journal:  Nat Rev Cardiol       Date:  2019-08       Impact factor: 32.419

9.  Maternal bisphenol a exposure impacts the fetal heart transcriptome.

Authors:  Kalyan C Chapalamadugu; Catherine A Vandevoort; Matthew L Settles; Barrie D Robison; Gordon K Murdoch
Journal:  PLoS One       Date:  2014-02-25       Impact factor: 3.240

10.  Serum and tissue biomarkers in aortic stenosis.

Authors:  Alkistis Kapelouzou; Loukas Tsourelis; Loukas Kaklamanis; Dimitrios Degiannis; Nektarios Kogerakis; Dennis V Cokkinos
Journal:  Glob Cardiol Sci Pract       Date:  2015-11-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.